Inducirani sputum - suvremena metoda za citološku analizu bronhalnih uzoraka by Marija Crnčević-Urek et al.
Acta clin Croat 2002; 41:89-93 Original Scientific Paper
89
INDUCED SPUTUM ∑ A METHOD FOR CYTOLOGIC
ANALYSIS OF BRONCHIAL SPECIMENS
Marija CrnËeviÊ-Urek1, Asja StipiÊ-MarkoviÊ1, Ika Kardum-Skelin2, Jagoda StipiÊ3,
Vesna Crnek-Kunstelj4 and Roman Urek1
1Department of Immunology and Pulmonology, Sveti Duh General Hospital; 2Merkur Clinical Hospital;
3Department of Neurology, Zagreb University Hospital Center; and 4Department of Biology,
School of Medicine, University of Zagreb, Zagreb, Croatia
SUMMARY ∑ Sputum induction by inhalation of hypertonic saline is a noninvasive method to obtain
secretions from the lower respiratory tract for cell counting and bacteriologic analyses. The aim of
this study was to introduce the method of induced sputum in our clinical practice and to get an
insight into airway inflammation by examining cell count differences in 15 asthmatic patients, 30
chronic obstructive pulmonary disease (COPD) patients and 15 healthy controls. Gradually increas-
ing concentrations (3%, 4%, 5%) of hypertonic saline were inhaled. Subjects were encouraged to cough
in order to expectorate. The quality of the sample was scored on the volume of the plugs (considered
to represent lower respiratory tract secretion) and salivary contamination (proportion of squamous
cells in the slides). A sample score ≥4 was considered adequate, 3 intermediate, and ≤2 inadequate.
Cytologic sputum analysis was done after microscopic selection of the plugs. The results showed that
inhalation of hypertonic saline is a safe method to get adequate sample for investigating various
inflamatory mechanisms in lower airways. There were differences in sputum from three groups of
subjects, i.e. a higher proportion of neutrophils in COPD (32%) in comparison to asthmatics (15%)
and healthy controls (10%). The percentage of alveolar macrophages also differed (COPD 56.5%,
asthmatics 46%, healthy 40%). Asthmatic patients had a higher proportion of eosinophils (asthmat-
ics 18.5%, COPD 1.9%, healthy 0.06%) and metachromatic cells (asthmatics 0.3%, COPD 0.039%,
healthy 0.014%).
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Introduction
The analysis of cells and mediators in the airway lin-
ing fluid from patients with pulmonary diseases has tra-
ditionally been performed in samples of spontaneously
expectorated sputum or on the fluid obtained by broncho-
scopy and lavage. Both sampling methods are limited in
their applicability. Many subjects are unable to produce
sputum spontaneously. Bronchosopy can only be em-
ployed to collect airway samples from study subjects who
are well enough to tolerate it. In addition, bronchosopy
cannot easily be applied repeatedly to follow the evolu-
tion of changes in airway lining fluid over short periods
of time.
Inhalation of hypertonic saline to produce sputum was
introduced almost four decades ago by Bickerman et al.1.
However, it was only for the last 8 years that the method
has been used to assess the indices of airway inflamma-
tion. The results have shown the method to be suitable,
valid, reliable2,3, and responsive4. The noninvasive nature
of the procedure is important because repeated examina-
tions are needed to learn more about the causes and treat-
ment of airway diseases. The mechanism by which hyper-
tonic saline induces sputum is not known. It may involve
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an osmotic effect5,6, increase in the  mucociliary clear-
ance7,8, or stimulation of glandular secretions.
There is evidence for inflammation in chronic ob-
structive pulmonary disease (COPD) but aspects of the
inflammation have not been studied as much as those in
asthma9. The study of Pin et al. resembles most of other
published analyses of induced sputum in asthmatic sub-
jects10. Evidence for bronchial inflammation have been
shown11. The aim of this study was to introduce the
method of induced sputum in our clinical practice and
to compare cellular characteristics of the specimens of
COPD and asthma patients, and healthy controls.
Subjects and Methods
Subjects
Subject characteristics are shown in Table 1. The study
population comprised 30 smokers with COPD, 15 stable
asthmatics, and 15 healthy subjects. Subjects with COPD
were current smokers (smoking is the main feature of
COPD) with a history of productive cough on most
mornings for more than 3 months/year for two consecu-
tive years, and forced expiratory volume in first second
(FEV1) <70% of the predicted value. Asthma was iden-
tified by a history of asthma symptoms and previous phy-
sician diagnosis, and objectively confirmed by metacholine
airway hyperresponsiveness (PC <2 mg/ml). Healthy sub-
jects had no history of respiratory disease, and had FEV1
>81% of the predicted value.
Study design
Study subjects attended the laboratory for 3 days
within a 2-week period, at the same time of the day. On
the first visit, subject characteristics were documented by
a questionnaire, spirometry ( Jaeger body plethysmogra-
phy), and allergy skin prick tests. Then they were in-
structed to record peak expiratory flow (PEF) in the
morning and in the evening, for 2 weeks, and to enter
values in a diary. On the second and third visit,  the diary
was checked, spirometry was performed, and sputum was
induced. If sputum could not be obtained on one of two
consecutive visits, another visit was scheduled and, if un-
successful, the subject was excluded.
Sputum processing
The reservoir of a Sonix 2000 ultrasonic nebulizer was
filled with 30 ml of sterile 3% saline, and all subjects in-
haled the nebulized solution for 10 min. The nebulizer
generates particles with a mean mass diameter of 3.9 mm
and output of 3.5 ml/min. The concentration of saline was
increased at 10-min intervals from 3% through 4% to 5%.
If the PEF, which was measured after each concentration,
fell by >20% from the starting value, or if troublesome
symptoms occurred, nebulization was discontinued. Sub-
jects were encouraged to cough throughout the procedure,
and they regularly interrupted inhalation of hypertonic
saline in order to expectorate sputum into a Petri dish,
where its macroscopic characteristics were recorded. Spu-
tum was processed as soon as possible within 2 h. The
quality of samples was assessed by estimating the volume
of lower respiratory tract secretions and the degree of sali-
vary contamination, as described by Pin et al.12.  The qual-
ity of sputum sample was scored by: (a) visual inspection
and inverted microscope examination (no plugs=0, ≤4.5x9
mm= 1, >4.5x9 mm = 2); (b) salivary contamination in
total cell count defined as percentage of squamous cells
among nucleated cells (>10%=0, ≤10%=1, 0%=2); and (c)
Table 1. Study subject characteristics
Characteristic COPD Asthma Healthy subjects
n=30 n=15 n=15
Male/female 22/8 8/7 8/7
Age (yrs) 49.4±5.4 34.3±3.2 37.2±3.9
Duration of disease 12.6±2.9 14.1±1.8 ∑
Smokers 30 (100%) ∑ ∑
FEV1 (% predicted) 55.6±6.5 65.5±8.5 104.5±17
Data are presented as mean±SD or n (%)
COPD=chronic obstructive pulmonary disease; FEV1= forced expiratory volume in first second
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salivary contamination in differential cell count by assess-
ing the proportion of squamous cells (too many squamous
cells to permit counting=0, enough squamous cells to
permit counting=1, no squamous cells=2). A sample score
≥4 was considered adequate, 3 intermediate, and ≤2 in-
adequate. Freshly prepared trypsin at a dilution of 1:10 in
distilled water was added to the sample for homogeniza-
tion. The samples were gently mixed and placed in the
incubator at 37 °C for 2 hours. Ten microliters of the
homogenized sputum were used to determine total cell
count using a standard hemacytometer. The remainder of
the homogenized sputum and saliva was centrifuged at
2000 rpm for 10 min. Cell pellets were cytocentrifuged.
Differential cell counts were performed by counting 400
nucleated cells on each of two slides fixed with methanol
and stained with May-Grünwald-Giemsa. Two further
slides were stained with 0.5% toluidine blue in 0.7 N hy-
drochloric acid at pH 0.1, and 1500 nucleated cells were
counted on each to obtain a differential count of metach-
romatic cells. The last two slides were fixed with phos-
phate buffer and stained with diluted Giemsa solution for
eosinophil count analysis.
Statistical analysis
Differential and total cell counts were calculated as
arithmetic means with 95% confidence intervals. Two-
tailed unpaired t-tests were used to compare cell counts
between groups. Significance was accepted at the 95%
level.
Results
The procedure was well tolerated in 57 patients. Sig-
nificant fall in PEF was observed in three patients, and
the induction was stopped. Adequate samples (one sample
of each concentration) were produced in 51 patients,
whereas six patients produced inadequate sputum samples.
Differences in total and differential cell counts in in-
duced sputum between study groups are shown in Table 2
and Fig. 1. There was no difference between the subjects
with COPD, asthmatics and normal subjects in total cell
counts, lymphocytes and bronchial epithelial cells. In com-
parison with asthmatics and healthy subjects, the sputum
from COPD patients contained higher proportions of neu-
trophils (COPD 32%, asthmatics 15%, healthy 10%) and
alveolar macrophages (COPD 56.5%, asthmatics 46%,
healthy 40%). Asthmatic patients had signficantly higher
Table 2. Differences in total and differential cell count in induced sputum
Group Total cell Differential cell count (% of total nucleated cells)
count
(x106/ml) Neutrophil Eosinophil Macrophage Lymphocyte Metachromatic Epithelial
COPD $+ $+ $+
(n=30) 4.1 (2.3-5.9) 32.0 (21.0-43.0) 1.9 (0.6-3.2) 56.5 (47.3-65.7) 1.23 (0.5-1.96) 0.039(0.009-0.068) 4.2(2.1-6.3)
Asthma $* *$
(n=15) 3.8 (1.9-5.7) 15.0 (10.0-20.0) 18.5 (2.5-30.1) 46.0 (31.2-60.8) 0.9 (0.3-1.5) 0.3(0.001-0.6) 2.9(2.0-3.8)
Healthy
(n=15) 3.1 (2.1-4.1) 10.0 (8.0-12.0) 0.06 (0.01-0.11) 40.0 (21.2-58.8) 1.55 (0.9-2.2) 0.014(0.005-0.023) 5.3(3.1-7.5)
Values are expressed as means; COPD=chronic obstructive pulmonary disease; $p<0.01 COPD - Asthma; *p<0.01 Asthma ∑ Healthy; +
















Fig. 1. Differential cell count in COPD, asthmatic and healthy sub-
jects.
CrnËevic-Urek M. et al. Induced sputum for bronchial cytology
92 Acta clin Croat, Vol. 41, No. 2, 2002
proportions of eosinophils (asthmatics 18.5%, COPD
1.9%, healthy 0.06%) and metachromatic cells (asthmatics
0.3%, COPD 0.039%, healthy 0.014%).
Discussion
The results of cytologic and bacteriologic analysis of
bronchial secretions depend on the sputum sample qual-
ity. Inhalation of an increasing concentration of hyper-
tonic saline enables an adequate specimen from the lower
respiratory tract to obtain in a noninvasive way. There has
been a concern that the inhalation by itself could alter the
cellular or fluid-phase contents of sputum13.
The aim of this study was to evaluate the safety and
usefulness of the induced sputum method, and to assess
the possible cytologic differences in patients with COPD
and asthma.
Comparison of various sputum contents showed dif-
ferences between the study groups. Asthmatics had higher
proportions of eosinophils and metachromatic cells, which
is comparable to the results of Pizzichini et al.2. In the
COPD group, neutrophils were the predominant cells.
The differential counts of macrophages were higher in
COPD group than in asthmatics and healthy subjects.
Similar results have been reported by Virchow et al.14.
Different cells appeared to be important in the patho-
genesis of airway inflammation in COPD15. The domi-
nanat effector cells are neutrophils, lymphocytes and
macrophages, however, eosinophils seem to be important
during exacerbations of COPD. In this study, induced
sputum in COPD exacerbation was not evaluated. Nev-
ertheless, we found a greater percentage of eosinophils in
COPD than in healthy controls, which may  suggest the
possible role of eosinophils in COPD.
The role of lymphocytes is important in bronchial
mucosa, but neutrophils are dominant in the sputum and
lumen of the airway11. This suggests that there may be
mechanisms which control the traffic of inflammatory
cells from the blood through the airway mucosa into the
lumen. Lymphocytes may be trapped in the mucosal cells
and neutrophils pass into the lumen as anti-infection cells.
Gibson et al. have also shown that neutrophils are pre-
dominant cells in COPD and their number correlates with
the degree of airflow obstruction16.
According to our results, we conclude that inhalation
of hypertonic saline is a useful, safe and noninvasive
method of obtaining adequate bronchial specimen. The
method enables repeated analyses in monitoring the state
of airway inflammation. The results of sputum examina-
tion in asthmatic and COPD patients show differences in
inflammatory cells, which suggests different pathophysi-
ologic mechanisms and helps in differential diagnosis.
References
1. BICKERMAN HA, SPROUL EE, BARACH AL. An aerosol
method of producing bronchial secretions in human subjects: a
clinical technique for the detection of lung cancer. Dis Chest
1958;33:347-62.
2. LOUKIDES S, BOUROS D, PAPATHEODOROU G, et al.
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with
cellular composition in induced sputum, spirometry and extent and
severity of disease. Chest 2002;121:81-7.
3. GREIFF L, ANDERSSON M, SVENSSON C, LINDEN M,
WOLLMER P, PERSSON CG. Demonstration of bronchial eosi-
nophil activity in seasonal allergic rhinitis by induced plasma exu-
dation combined with induced sputum. Thorax 1999;54:33-6.
4. POLOSA R, CIAMARRA I, MANGANO G, PROSPERINI
G, PISTORIO MP, VANCHERI C, CRIMI N. Bronchial
hyperresponsiveness and airway inflammation markers in non-
asthmatics with allergic rhinitis. Eur Respir J 2000;15:30-5.
5. JONJENJA RC, De JONGSTE JC, RAATGEEP RC, BONTA
IL, KERREBIJN KF. Effects of changes in osmolarity on isolated
human airways. J Appl Physiol 1990;68:1568-75.
6. EGGLESTON PA, KAGEI-SOBOTA A, LICHTENSTEIN
LM. A comparison of osmotic activation of basophils and human
lung mast cells. Am Rev Respir Dis 1987;135:1043-8.
7. PAVIA DM, THOMSON ML, CLARKE SW. Enhanced clear-
ance of secretions from human lung after the administration of
hypertonic saline aerosol. Am Rev Respir Dis 1978;117:199-203.
8. ROBINSON M, KING M, TOMKIEVICZ RP, REGNIS JA,
BAILEY DL, PEAT J, BYE PTP. Effect of hypertonic saline,
amiloride and cough on mucociliary clearance in patients with cys-
tic fibrosis (abstract). Am J Respir Crit Care Med 1994;149: A669.
9. SILKOFF PE, MARTIN D, PAK J, et al. Exhaled nitric oxide and
induced sputum analysis as markers of airway inflammation in
subjects with COPD. Chest 2000;117(5 Suppl 1):281S.
10. PIN I, FREITAG AP, O’BYRNE PM, GIRGIS-GABARDO A,
WATSON RM, DOLOVICH J, DENBURG JA, HARGREAVE
FE. Changes in cellular profile of induced sputum after allergen-
induced asthmatic response. Am Rev Respir Dis 1992;145:1265-9.
11. van ZUIJLEN DA, van de GRAAF EA, van BOLHUIS EM, et
al. Measuring plasma exudation in nasal lavage fluid and induced
sputum as tool for studying respiratory tract inflammation. J
Immunol Methods 2001;256:1-10.
12. PIN I, GIBSON PG, KOLENDOWICZ R, GIRGIS-GA-
BARDO A, DENBURG JA, HARGREAVE FE, DOLOVICH
J. Use of induced sputum cell counts to investigate airway inflam-
mation in asthma.Thorax 1992;47:25-9.
13. SONT JK, BOOMS P, BEL EH, VANDENBROUCKE JP,
STERK PJ. The determinants of airway hyperresponsiveness to
hypertonic saline in atopic asthma in vivo: relationship with sub-
populations of peripheral blood leukocytes. Clin Exp Allergy
1993;23:678-88.
14. VIRCHOW JC, HOLSCHER U, VIRCHOW C. Sputum ECP
levels correlate with parameters of airflow obstruction. Am Rev
Respir Dis 1992;146:604-6.
CrnËevic-Urek M. et al. Induced sputum for bronchial cytology
Acta clin Croat, Vol. 41, No. 2, 2002 93
15. SILKOFF PE, MARTIN D, PAK J, et al. Exhaled nitric oxide
correlated with induced sputum findings in COPD. Chest
2001;119:1049-55.
Saæetak
INDUCIRANI SPUTUM ∑ SUVREMENA METODA ZA CITOLO©KU ANALIZU BRONHALNIH UZORAKA
M. CrnËeviÊ-Urek, A. StipiÊ-MarkoviÊ, I. Kardum-Skelin, J. StipiÊ, V. Crnek-Kunstelj i R. Urek
Inducirani sputum je metoda potpomognutog iskaπljavanja putem inhaliranja rastuÊih koncentracija (3%, 4%, 5%) hipertoniËne
otopine NaCl. Tim neinvazivnim naËinom mogu se izbjeÊi invazivnije dijagnostiËke metode poput bronhoskopije, a dobiti
prikladni uzorci sekreta iz donjih diπnih putova. Cilj ovoga istraæivanja bio je: a) uvesti metodu induciranog sputuma u naπu
kliniËku praksu, b) ispitati njenu sigurnost i uspjeπnost indukcije i c) usporediti ukupan i diferencijalni broj stanica u 15
bolesnika s astmom, 30 s KOPB i 15 zdravih ispitanika. Kvaliteta sputuma procjenjivana je na temelju koliËine bronhalnih
odljevaka (ËepiÊa koji dokazuju da se radi o sekretu iz donjeg diπnog sustava) te udjela stanica ploËastog epitela (dokaz da
uzorak Ëini slina). Bodovi ≥4 pokazuju da je uzorak primjeren, 3 da je srednje kvalitete, a bodovi ≤2 da nije prikladan za
analizu. Rezultati su pokazali da je inhalacija hipertoniËne otopine sigurna metoda za dobivanje prikladnih uzoraka kojima se
moæe dobiti uvid u razliËite upalne mehanizme kod bolesnika s opstruktivnim pluÊnim bolestima. U bolesnika s KOPB utvren
je znaËajno veÊi udio neutrofila (KOPB 32%, astma 15%, zdravi 10%) i alveolarnih makrofaga (KOPB 56,5%, astma 46%,
zdravi 40%) u odnosu na druge dvije ispitivane skupine. U bolesnika s astmom utvren je znaËajno veÊi udio eozinofila (astma
18,5%, KOPB 1,9%, zdravi 0,06%) i metakromatskih stanica (astma 0,3%, KOPB 0,039%, zdravi 0,014%).
KljuËne rijeËi: Sputum, citologija; PluÊne bolesti ∑ kroniËne opstruktivne, dijagnostika; Astma, dijagnostika
16. GIBSON PG, GIRGIS-GABARDO A, MORRIS MM, et al.
Cellular characteristics of sputum from patients with asthma and
chronic bronchitis. Thorax 1989;44:693-9.
